NCT06172959

Brief Summary

The purpose of this study is to examine the short-term impact of Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) on respiratory function in patients with lung cancer. As a secondary outcome, this research will evaluate the effect of the music intervention on respiratory quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable lung-cancer

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

February 21, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

3 months

First QC Date

December 7, 2023

Last Update Submit

September 3, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in Maximum Phonation Time (MPT) in seconds

    Maximum Phonation Time (MPT) measures the number of seconds a participant can sustain a phonated sound.

    Baseline, up to 30-minutes (Post-Intervention)

  • Respiratory Rate

    Measured by the number of breaths per minute

    Up to 30-minutes

  • Change in Dyspnea measured by Dyspnea-12 Questionnaire

    Scores range from 0 to 3. Higher scores suggest more severity in shortness of breath

    Baseline, up to 1 month

  • Change in Dyspnea measured by Modified Borg Scale

    Scores change from 0 to 10. Higher scores suggest more severity in shortness of breath

    Baseline, up to 30-minutes (Post-Intervention)

  • Change in Respiratory Quality of Life measured by St.Georges Respiratory Questionnaire

    A composite score will be obtained, ranging from 0 to 100. Higher scores indicate worst respiratory quality of life

    Baseline, up to 1 month

  • Change in Dyspnea measured by Cancer Dyspnea Scale

    Scores range from 1 (Not at all) to 5 (Very much). Higher scores suggest more severity of dyspnea

    Baseline, up to 1 month

Study Arms (1)

Vocal Therapy Group

EXPERIMENTAL

Participants in this group will receive Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) for up to three weeks

Behavioral: Vocal Intonation Therapy (VIT)Behavioral: Therapeutic Singing (TS)

Interventions

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Vocal Intonation Therapy is a music therapy technique consisting of breathing and vocal exercises to target respiratory function and vocal quality.

Vocal Therapy Group

Participants will receive 12 individual sessions, four times a week (i.e., any four days of seven days) over three weeks. Each session will be held virtually for 30-minutes. Therapeutic Singing is a music therapy technique used to work on the rehabilitation of vocal and respiratory function.

Vocal Therapy Group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will include three patients diagnosed with lung cancer, stages I-III, who have undergone a thoracentesis or thoracotomy in the last 12 months. Thoracic surgical procedures include pulmonary lobectomy or cancer-related surgical procedure (e.g., pneumonectomy). This diagnosis must be made by the patient's oncologist and medical team.
  • The age range will be 40 to 80 years old. Both female and male participants from any race and ethnicity will be included in the study.
  • The study will include English and Spanish speakers only.
  • Patients must have less than five years of voice training experience (e.g., choir, private voice lessons).

You may not qualify if:

  • Patients in respiratory failure
  • Individuals with severe neurological and hearing impairments.
  • Patients with diagnosed dysphonia and individuals who have undergone a laryngectomy
  • Participants that do not have access to an electronic device, either an iPad, tablet, or laptop, as well as reliable internet access. They will also need to have adequate knowledge of technology or participate with a caregiver who knows how to navigate Zoom.
  • Participants who do not have access to a quiet space. Headphones are optional for this study.
  • Prisoners
  • Persons under the age of 40 or over the age of 80.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Coral Gables, Florida, 33146, United States

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Teresa Lesiuk, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 7, 2023

First Posted

December 15, 2023

Study Start

February 21, 2024

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations